Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:35:53 EDT Mon 29 Apr 2024
Enter Symbol
or Name
USA
CA



News for C:MDNA from 2023-04-30 to 2024-04-29 - 37 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-04-26 09:09C:MDNAMedicenna Therapeutics Corp2.49News ReleaseMedicenna arranges $20M private placement
2024-04-26 08:09C:MDNAMedicenna Therapeutics Corp1.95Resume TradingMedicenna Therapeutics resuming at the open
2024-04-26 08:02C:MDNAMedicenna Therapeutics Corp1.95Halt TradingMedicenna Therapeutics halted at the open
2024-04-09 16:57C:MDNAMedicenna Therapeutics Corp1.50News ReleaseMedicenna presents MDNA11 clinical data at AACR
2024-04-09 15:21C:MDNAMedicenna Therapeutics Corp1.70News ReleaseMedicenna presents preclinical data on MDNA113 at AACR
2024-02-14 12:43C:MDNAMedicenna Therapeutics Corp0.86News ReleaseMedicenna Therapeutics' Dec. 31 cash at $21.8-million
2024-02-14 07:40C:MDNAMedicenna Therapeutics Corp0.66SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-02-14 07:40C:MDNAMedicenna Therapeutics Corp0.66SEDAR Interim MD & ASEDAR Interim MD & A
2024-02-13 11:13C:MDNAMedicenna Therapeutics Corp0.67News ReleaseMedicenna doses first patient in combo Ability-1 study
2024-01-12 17:41C:MDNAMedicenna Therapeutics Corp0.40News ReleaseMedicenna appoints MNP as auditor
2024-01-09 10:36C:MDNAMedicenna Therapeutics Corp0.43News ReleaseMedicenna begins enrolment for Ability combo study
2023-12-21 19:39C:MDNAMedicenna Therapeutics Corp0.41News ReleaseMedicenna has conditional TSX OK for warrant extension
2023-12-19 10:10C:MDNAMedicenna Therapeutics Corp0.415News ReleaseMedicenna begins trading on OTCQB Venture Market
2023-11-17 11:15C:MDNAMedicenna Therapeutics Corp0.44News ReleaseMedicenna talks survival benefit in bizaxofusp trial
2023-11-14 14:43C:MDNAMedicenna Therapeutics Corp0.53News ReleaseMedicenna Therapeutics' Sept. 30 cash at $25.7-million
2023-11-14 08:42C:MDNAMedicenna Therapeutics Corp0.53SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-14 08:38C:MDNAMedicenna Therapeutics Corp0.53SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-06 10:03C:MDNAMedicenna Therapeutics Corp0.435News ReleaseMedicenna presents phase 1 MDNA11 study data at SITC
2023-11-03 12:07C:MDNAMedicenna Therapeutics Corp0.25News ReleaseMedicenna details preclinical MDNA113 data at SITC
2023-10-27 10:05C:MDNAMedicenna Therapeutics Corp0.335News ReleaseMedicenna receives Nasdaq delisting notice
2023-10-25 09:48C:MDNAMedicenna Therapeutics Corp0.36News ReleaseMedicenna doses first patient in Ability dose expansion
2023-10-10 13:17C:MDNAMedicenna Therapeutics Corp0.39News ReleaseMedicenna appoints Gardner chief medical officer
2023-10-03 09:57C:MDNAMedicenna Therapeutics Corp0.385News ReleaseMedicenna details preclinical MDNA223 data at AACR
2023-09-28 17:21C:MDNAMedicenna Therapeutics Corp0.38News ReleaseMedicenna shareholders elect five directors at AGM
2023-08-28 11:25C:MDNAMedicenna Therapeutics Corp0.51News ReleaseMedicenna Therapeutics appoints Caravella as CFO
2023-08-14 10:55C:MDNAMedicenna Therapeutics Corp0.50News ReleaseMedicenna appoints Meadows as chief business officer
2023-08-09 10:40C:MDNAMedicenna Therapeutics Corp0.56News ReleaseMedicenna begins Ability monotherapy dose expansion
2023-08-08 12:31C:MDNAMedicenna Therapeutics Corp0.56News ReleaseMedicenna appoints Yavari as advisory committee chair
2023-08-04 12:04C:MDNAMedicenna Therapeutics Corp0.50News ReleaseMedicenna to hold Ability study update call Aug. 9
2023-08-01 12:40C:MDNAMedicenna Therapeutics Corp0.62News ReleaseMedicenna receives U.S. patent for IL-2 superkines
2023-07-28 10:35C:MDNAMedicenna Therapeutics Corp0.58News ReleaseMedicenna spends $2.8-million on R&D in Q1 2024
2023-07-28 09:58C:MDNAMedicenna Therapeutics Corp0.58SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-07-05 11:51C:MDNAMedicenna Therapeutics Corp0.65News ReleaseMedicenna receives cond. OK to extend warrants to 2024
2023-06-27 16:36C:MDNAMedicenna Therapeutics Corp0.59SEDAR Annual ReportSEDAR Annual Report
2023-06-27 16:34C:MDNAMedicenna Therapeutics Corp0.59SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2023-06-27 16:34C:MDNAMedicenna Therapeutics Corp0.59SEDAR MD & ASEDAR MD & A
2023-06-27 13:57C:MDNAMedicenna Therapeutics Corp0.59News ReleaseMedicenna cash at $33.6-million at March 31